Article

The Case for a Clinical Voice in Employer Health Strategy

Partner Medical
August 17, 2026
5 min read
What's missing when benefits strategy is built without a clinical stakeholder.

The Missing Input: Bringing Clinical Intelligence Into Benefit Design

Executive Summary

  • Benefit plan design and benefit plan delivery typically draw on two disconnected bodies of evidence: a claims history compiled after the fact, and a clinical relationship the design process has no visibility into.
  • Claims data is structurally retrospective — subject to the adjudication and run-out cycles built into how third-party administrators report it — and records what was billed, not the clinical reasoning behind it.
  • Health insurers rank as the least trusted industry Forrester measured in 2025 (25% of non-customers, 54% of customers describe them as trustworthy), while patients continue to name their own physician as the most trusted source for a health-related decision.
  • A dedicated primary care relationship performs well on its own terms, but without visibility into a specific plan's negotiated rates and cost-containment priorities, that same relationship can direct care toward clinically sound but financially unintended paths.
  • Embedding clinical input into both the design and the execution of a benefit plan — the same clinician informing the strategy and then operating inside it — closes a loop that neither claims-based design nor stand-alone care delivery can close on its own.

The Input Missing From Plan Design

Plan design runs through a broker, a third-party administrator, a consultant, and the employer, each contributing a distinct body of expertise — market access and negotiation, claims administration, actuarial and regulatory guidance, organizational priorities. What that process typically lacks is a source of clinical intelligence describing what is happening in the population in real time, and continuity of that same intelligence once the plan moves from design into execution. The absence is not a shortfall in any one party's function — a broker is not positioned to interpret clinical data, and a TPA's role is administrative rather than diagnostic. It is a gap in the inputs available to the process as a whole.

The Structural Limits of Claims-Based Design

The evidence a benefit strategy is typically built on has a specific character worth stating precisely. Claims data is retrospective by construction: a claim is reported, adjudicated, and reconciled against a run-out period that commonly extends well beyond the date of service before it becomes part of a usable report. That data also records what was billed, not the clinical reasoning behind it — it can show that an emergency department visit occurred, not whether it followed from a genuine emergency or a gap in after-hours access. And it originates from the party a workforce trusts least. A 2025 Forrester survey found only 25% of non-customers and 54% of customers describe their health insurer as trustworthy, the lowest score of any industry the firm measured. The same population, surveyed separately by EBRI and Greenwald Research, continued to name their own health care provider as the most trusted source for a health-related decision. None of this makes claims data unusable — it remains the most complete record of what a plan actually paid for. It does mean that data alone, compiled after the fact by the party the relationship trusts least, is a limited foundation for a strategy meant to change what happens next.

The Limits of Care Delivery Without Design Visibility

A dedicated primary care relationship, evaluated on its own terms, performs well: continuity of care is associated with lower mortality, fewer hospital admissions, and fewer emergency department visits, and specialty referrals from a trusted physician complete at rates far above an unprompted benefit offer. But a physician managing that relationship without visibility into a specific plan's design — its negotiated rates, its preferred specialists and imaging centers, its funded cost-containment programs — is optimizing on clinical judgment alone. The same clinically sound referral can route to a hospital-based imaging center at two to three times the cost of an equivalent scan at a freestanding facility, or to a specialist outside the plan's negotiated network, not because the clinical decision was wrong, but because the plan's cost architecture was never part of the decision. Value generated at the point of care can leak downstream of it, in a system where care delivery has no structural connection to what the plan was built to encourage.

Embedding Clinical Input Across the Benefit Lifecycle

Closing that loop means the same clinical relationship functions at two points rather than one. At the design stage, a clinician with visibility into population-level health data — condition prevalence, utilization patterns, gaps in access — contributes a body of evidence the broker, TPA, and employer do not otherwise have, informing decisions about which programs to fund, which specialists and facilities to prioritize, and where a plan's cost-containment effort should concentrate. At the execution stage, that same clinician operates inside the resulting design, directing referrals, diagnostics, and program enrollment toward the choices the plan was built around. Outcome and cost data generated through that execution then returns to inform the next design cycle. The broker's market expertise and the TPA's administrative function are unchanged; what changes is that clinical judgment and plan architecture are no longer developed and applied by parties with no visibility into each other's work.

This produces three specific improvements over the current default:

  • A more current and clinically grounded understanding of what a workforce needs and what it is likely to cost, ahead of when that need would otherwise surface in a claims report.
  • Care navigation delivered through a resource the workforce already trusts, weighing both clinical outcomes and the plan's cost-containment priorities at the point of a referral or care decision.
  • Visibility across the full arc from design to outcome, allowing cost containment to operate upstream of a claim rather than in response to one.

How This Connects to the Rest of a Benefits Strategy

This function depends on, and reinforces, the other three pillars from which Partner Medical creates value. It depends on Care Delivery for the underlying relationship — clinical intelligence of this kind is a byproduct of continuity, not a service that attaches to a rotating panel. It depends on Data & Transparency to make the clinical input auditable rather than anecdotal, feeding the same encounter-level detail into both the design conversation and the eventual measurement of whether the resulting decisions worked. And it is reinforced by Risk Sharing, since a clinician whose compensation is tied to the plan's performance has a direct stake in whether a recommendation is adopted, not only in whether it is offered.

Contact us to learn more about how Partner Medical works with self-insured stakeholders?

Partner Medical  ·  info@partnermedical.org

References

1. Forrester Research. 2025 Customer and Brand Experience Survey, health insurer trust findings, cited in InsuranceNewsNet, "Health insurers face trust crisis, Forrester 2025 survey finds."

2. Employee Benefit Research Institute (EBRI) and Greenwald Research. 2025 Consumer Engagement in Health Care Survey.

3. Engström, S.G., André, M., Arvidsson, E., Östgren, C.J., Troein, M., Borgquist, L. "Personal GP continuity improves healthcare outcomes in primary care populations: a systematic review." British Journal of General Practice, 2025;75(757):e518.

4. Forrest, C.B., Shadmi, E., Nutting, P.A., Starfield, B. "Specialty Referral Completion Among Primary Care Patients: Results From the ASPN Referral Study." Annals of Family Medicine, 2007;5(4):361-367.

5. Wright, J.R., Madhusudhan, D.K., Lawrence, D.C., et al. "Costs of Specialist Referrals From Employer-Sponsored Integrated Health Care Clinics Are Lower Than Those From Community Providers." Journal of General Internal Medicine, 2022.

6. Hospital vs. freestanding imaging center pricing: industry cost analyses aggregating CMS billing data (ranges cited are illustrative and vary by region and plan).

7. Industry analysis of third-party administrator claims run-out and adjudication cycles, e.g. Roundstone Insurance, "10 Ways To Find the Right TPA Partner."